Clinical Trial Update: TEGSEDI Pregnancy Surveillance Program

View source ↗

Summary

Clinical trial update shows a TEGSEDI pregnancy surveillance program for hereditary transthyretin-mediated amyloidosis with polyneuropathy is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy

Drugs mentioned

• TEGSEDI (inotersen)

Snippet

Sponsor: Akcea Therapeutics | Conditions: Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy, Pregnancy | Status: NOT_YET_RECRUITING